The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wang, Qihui ^a   Gao, Pan ^b   Wang, Xiaoyi ^b   Duan, Yixiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLISM; METABOLOME; METABOLOMICS; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SALIVA;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NEOPLASM STAGING; ROC CURVE; SALIVA;

EID: 84923383232     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06802     Document Type: Article

References (41)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2013
2. Rezende, T. M. B., Freire, M. d. S. & Franco, O. L. Head and neck cancer. Cancer 116, 4914-4925 (2010
3. Liu, S. A. et al.Nutritional factors and survival of patients with oral cancer. Head& neck 28, 998-1007 (2006
4. Ehsan, S. et al. Disease Specific Biomarkers of Abdominal Aortic Aneurysms Detected by Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry. Eur J Vasc Endovasc 44, 52-54 (2012
5. Wang, Q., Gao, P., Wang, X. & Duan, Y. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta 427, 79-85 (2013
6. Pfaffe, T., Cooper-White, J., Beyerlein, P., Kostner, K. & Punyadeera, C. Diagnostic Potential of Saliva: Current State and Future Applications. Clin Chem 57, 675-687 (2011
7. Cubbon, S., Antonio, C.,Wilson, J. & Thomas-Oates, J. Metabolomic applications of HILIC-LC-MS. Mass Spectrom Rev 29, 671-684 (2010
8. Pereira, H., Martin, J. F., Joly, C., Sébédio, J. L. & Pujos-Guillot, E. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics 6, 207-218 (2010
9. Shintani, S., Hamakawa, H., Ueyama, Y., Hatori, M. & Toyoshima, T. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg 39, 68-74 (2010
10. Zimmermann, B. G. &Wong, D. T. Salivary mRNA targets for cancer diagnostics. Oral Oncol 44, 425-429 (2008
11. Zhang, L. et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci 69, 3341-3350 (2012
12. Spratlin, J. L., Serkova, N. J. & Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15, 431-440 (2009
13. Aimetti, M., Cacciatore, S., Graziano, A. & Tenori, L. Metabonomic analysis of saliva reveals generalized chronic periodontitis signature. Metabolomics 8, 465-474 (2012
14. Nicholson, J. K. & Lindon, J. C. Systems biology: metabonomics. Nature 455, 1054-1056 (2008
15. Mishur, R. J. & Rea, S. L. Applications of mass spectrometry to metabolomics and metabonomics: Detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31, 70-95 (2012
16. Yan, S. K. et al. Metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. Oral Oncol 44, 477-483 (2008
17. Tiziani, S., Lopes, V.&Günther, U. L. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 11, 269-276 (2009
18. Lin, L. et al. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery. J Proteome Res 10, 1396-1405 (2011
19. An, Z. et al. Integrated Ionization Approach for RRLC2 MS/MS-based Metabonomics: Finding Potential Biomarkers for Lung Cancer. J Proteome Res 9, 4071-4081 (2010
20. Theodoridis, G., Gika, H. G. &Wilson, I. D. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trends Ana. Chem 27, 251-260 (2008
21. Wei, J. et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129, 2207-2217 (2011
22. Tsutsui, H. et al. Practical analytical approach for the identification of biomarker candidates in prediabetic state based upon metabonomic study by ultraperformance liquid chromatography coupled to electrospray ionization time-of-flight mass spectrometry. J Proteome Res 9, 3912-3922 (2010
23. Qiu, Y. et al. Serum metabolite profiling of human colorectal cancer using GC2 TOFMS and UPLC2 QTOFMS. J Proteome Res 8, 4844-4850 (2009
24. Chen, S. et al. Pseudotargeted Metabolomics Method and Its Application in Serum Biomarker Discovery for Hepatocellular Carcinoma Based on Ultra High-Performance Liquid Chromatography/Triple Quadrupole Mass Spectrometry. Anal Chem 85, 8326-8333 (2013
25. Alpert, A. J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr A 499, 177-196 (1990
26. Liu, J. & Duan, Y. Saliva: A potential media for disease diagnostics and monitoring. Oral Oncol 48, 569-577 (2012
27. Eriksson, L. Multi-And megavariate data analysis; MKS Umetrics AB, 2006.
28. Jia, L., Chen, J., Yin, P., Lu, X. & Xu, G. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics 4, 183-189 (2008
29. Huo, T. et al. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride. J Pharm Biomed Anal 49, 976-982 (2009
30. Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009
31. Dhup, S., Kumar Dadhich, R., Ettore Porporato, P. & Sonveaux, P. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 18, 1319-1330 (2012
32. Kim, J. W. & Dang, C. V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66, 8927-8930 (2006
33. Hori, S. et al. A metabolomic approach to lung cancer. Lung Cancer 74, 284-292 (2011
34. Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T. & Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6, 78-95 (2009
35. Mavri-Damelin, D. et al.Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. Int J biochem Cell B 39, 555-564 (2007
36. Deignan, J. L. et al. Ornithine deficiency in the arginase double knockout mouse. Mol Genet Metab 89, 87-96 (2006
37. Gerlo, E. et al. Gas chromatographic-mass spectrometric analysis of N-Acetylated amino acids: The first case of aminoacylase I deficiency. Anal Chim Acta 571, 191-199 (2006
38. Bahar, G., Feinmesser, R., Shpitzer, T., Popovtzer, A. & Nagler, R. M. Salivary analysis in oral cancer patients. Cancer 109, 54-59 (2007
39. Ryland, L. K., Fox, T. E., Liu, X., Loughran, T. P. & Kester, M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther 11, 138-149 (2011
40. Rebouche, C. J. & Paulson, D. J. Carnitine metabolism and function in humans. Annu Rev Nutr 6, 41-66 (1986
41. Busquets, S. et al. L-Carnitine: An adequate supplement for a multi-targeted antiwasting therapy in cancer. Clin Nutr 31, 889-895 (2012).